SLP

Simulations Plus, Inc. NASDAQ

Healthcare ·Medical - Healthcare Information Services ·US · simulations-plus.com

$15.15

Mkt Cap $306.1M

52w Low $11.09 17.7% of range 52w High $34.01

50d MA $12.77 200d MA $15.36

P/E (TTM) -4.6x

EV/EBITDA 17.3x

P/B 2.4x

Debt/Equity 0.0x

ROE -47.3%

P/FCF 16.4x

RSI (14) —

ATR (14) —

Beta 1.19

50d MA $12.77

200d MA $15.36

Avg Volume 366.0K

About

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which simulates the absorption and drug interaction of compoun…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Apr 9, 2026	AMC	0.27	0.35	+29.6%	12.99	+19.8%	+0.4%	-0.3%	+2.9%	+12.7%	+8.7%	—
Jan 8, 2026	AMC	0.18	0.13	-27.8%	18.05	-6.5%	+8.6%	+4.8%	+10.1%	+10.2%	+12.2%	—
Dec 1, 2025	AMC	0.10	0.10	+0.0%	17.11	+2.6%	+14.1%	+18.9%	+19.8%	+14.8%	+14.3%	—
Jul 14, 2025	AMC	0.26	0.45	+73.1%	17.47	-12.6%	-25.8%	-26.1%	-26.8%	-28.7%	-24.8%	—
Apr 3, 2025	AMC	0.25	0.31	+24.0%	23.82	-2.2%	+7.8%	+4.2%	+1.8%	+7.3%	+8.1%	—
Jan 7, 2025	AMC	0.18	0.17	-5.6%	30.39	-16.6%	-7.2%	-7.0%	-4.9%	-5.4%	-1.8%	—
Oct 23, 2024	AMC	0.07	0.06	-9.1%	33.98	+1.5%	-8.9%	-9.7%	-9.1%	-12.4%	-15.6%	—
Jul 2, 2024	AMC	0.15	0.15	+0.0%	46.86	-8.6%	-14.9%	-17.0%	-14.9%	-15.6%	-18.0%	—
Apr 3, 2024	AMC	0.19	0.20	+5.3%	38.46	+16.8%	+23.6%	+24.0%	+28.5%	+31.9%	+24.4%	—
Jan 3, 2024	AMC	0.10	0.10	+0.0%	43.18	+1.3%	-5.0%	-7.4%	-9.1%	-10.7%	-10.9%	—
Oct 25, 2023	AMC	0.18	0.18	+0.0%	39.11	-11.8%	-14.7%	-13.2%	-13.4%	-9.8%	-11.2%	—
Jul 6, 2023	AMC	0.20	0.20	+0.0%	41.29	-2.2%	+1.6%	+6.4%	+9.9%	+10.6%	+13.7%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 10	TD Cowen	Maintains	Hold → Hold	—	$12.99	$15.56	+19.8%	+0.4%	-0.3%	+2.9%	+12.7%	+8.7%
Jan 8	TD Cowen	Maintains	Hold → Hold	—	$18.99	$18.70	-1.5%	-5.0%	+3.2%	-0.4%	+4.6%	+4.7%
Dec 18	BTIG	Downgrade	Buy → Neutral	—	$18.70	$18.10	-3.2%	-0.7%	+0.3%	+3.4%	+3.4%	+2.6%
Jul 15	Stephens & Co.	Maintains	Overweight → Overweight	—	$17.47	$15.27	-12.6%	-25.8%	-26.1%	-26.8%	-28.7%	-24.8%
Jul 15	KeyBanc Capital Markets	Downgrade	Overweight → Sector Weight	—	$17.47	$15.27	-12.6%	-25.8%	-26.1%	-26.8%	-28.7%	-24.8%
Jul 14	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$16.96	$17.59	+3.7%	+3.0%	-23.5%	-23.9%	-24.6%	-26.5%
Jul 7	BTIG	Maintains	Buy → Buy	—	$17.75	$17.60	-0.8%	-5.2%	-1.4%	-1.2%	-1.0%	-4.5%
Jun 18	JMP Securities	Maintains	Market Perform → Market Perform	—	$18.32	$18.22	-0.5%	-1.3%	-5.4%	-6.8%	-6.4%	-7.6%
Jun 13	Craig-Hallum	Maintains	Buy → Buy	—	$20.05	$19.76	-1.4%	-4.9%	-5.5%	-8.6%	-9.8%	-13.6%
Apr 16	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$32.81	$33.11	+0.9%	-1.9%	-0.4%	+3.3%	+7.8%	+7.5%
Jan 24	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$33.50	$33.73	+0.7%	+0.8%	+1.5%	+1.5%	+0.9%	+2.3%
Jan 8	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$30.39	$25.36	-16.6%	-7.2%	-7.0%	-4.9%	-5.4%	-1.8%
Oct 24	BTIG	Maintains	Buy → Buy	—	$33.98	$34.50	+1.5%	-8.9%	-9.7%	-9.1%	-12.4%	-15.6%
Jul 3	Craig-Hallum	Maintains	Buy → Buy	—	$46.86	$42.85	-8.6%	-14.9%	-17.0%	-14.9%	-15.6%	-18.0%
Jun 13	Craig-Hallum	Maintains	Buy → Buy	—	$49.26	$50.11	+1.7%	-1.3%	-5.3%	-4.5%	-4.2%	-4.1%
Jun 13	Oppenheimer	Maintains	Outperform → Outperform	—	$49.26	$50.11	+1.7%	-1.3%	-5.3%	-4.5%	-4.2%	-4.1%
Jan 4	Craig-Hallum	Maintains	Buy → Buy	—	$43.18	$43.74	+1.3%	-5.0%	-7.4%	-9.1%	-10.7%	-10.9%
Jul 7	Oppenheimer	Maintains	Outperform → Outperform	—	$41.29	$40.37	-2.2%	+1.6%	+6.4%	+9.9%	+10.6%	+13.7%
Jun 21	Oppenheimer	Maintains	Outperform → Outperform	—	$46.65	$46.76	+0.2%	+2.4%	+0.7%	-2.7%	-4.1%	-6.1%
May 9	BTIG	Maintains	Buy → Buy	—	$40.45	$41.13	+1.7%	+2.2%	+5.6%	+4.5%	+2.1%	+1.3%
Apr 6	Oppenheimer	Maintains	Outperform → Outperform	—	$41.83	$42.66	+2.0%	+1.1%	+3.7%	+4.8%	+5.6%	+8.0%
Aug 29	Raymond James	Maintains	Outperform → Outperform	—	$62.94	$62.28	-1.0%	-2.7%	-3.9%	-4.6%	-6.6%	-9.1%
Jul 7	Craig-Hallum	Maintains	Buy → Buy	—	$51.28	$52.54	+2.5%	+7.9%	+5.5%	+6.8%	+5.4%	+7.5%
Oct 26	Craig-Hallum	Upgrade	Hold → Buy	—	$41.57	$43.00	+3.4%	+10.8%	+10.9%	+16.9%	+21.5%	+19.7%
Jul 13	Raymond James	Maintains	Outperform → Outperform	—	$53.40	$44.96	-15.8%	-17.5%	-16.6%	-17.4%	-18.8%	-14.3%
Jan 12	Craig-Hallum	Downgrade	Buy → Hold	—	$79.33	$75.01	-5.4%	-10.3%	-8.9%	-8.1%	-10.3%	-8.7%
Oct 16	Raymond James	Maintains	Outperform → Outperform	—	$71.90	$73.38	+2.1%	+0.5%	-2.9%	-3.3%	-6.0%	-2.6%
Sep 8	Oppenheimer	Maintains	Outperform → Outperform	—	$59.97	$56.72	-5.4%	+4.2%	+12.2%	+10.3%	+4.8%	+8.3%
Jan 6	Craig-Hallum	Maintains	Buy → Buy	—	$28.79	$28.88	+0.3%	+7.7%	+7.8%	+6.3%	+10.0%	+15.9%

Recent Filings

8-K · 7.01 ! Medium

Unknown — 8-K 7.01: Regulation FD Disclosure

This boilerplate disclosure indicates SLP provided forward-looking guidance that may not materialize, creating stock volatility risk if actual results disappoint investor expectations.

Apr 9

8-K · 5.02 !!! Very High

Simulations Plus, Inc. -- 8-K 5.02: Executive Change

The departure of an executive at Simulations Plus could signal internal uncertainty or strategic shifts, potentially impacting investor confidence unless a capable replacement is promptly announced.

Feb 18

Data updated apr 27, 2026 1:45am · Source: massive.com